Paul Gratzer

Paul Gratzer is an Associate Professor in the Department of Process Engineering and Applied Science at Dalhousie University, affiliated with the School of Biomedical Engineering. His research focuses on developing decellularization technologies for soft-tissue regeneration, including skin, blood vessels, and cartilage. He leads a collaborative team translating research into clinical applications through DeCell Technologies Inc., a company he co-founded to commercialize wound-healing matrices for diabetic patients and surgical reconstructions.

Key projects include decellularized porcine auricular cartilage for ear reconstruction (collaborating with Dr. Paul Hong) and advanced tissue products addressing chronic wounds. His work emphasizes biocompatible scaffolds, cell-matrix interactions, and technology transfer. Notable publications span reviews on tympanic membrane regeneration to foundational studies on decellularization techniques in ligament engineering.

Gratzer’s innovations aim to bridge biomedical engineering and clinical practice, with media coverage highlighting breakthroughs in diabetic wound solutions and bioengineered skin substitutes. His research integrates biomaterials science, tissue engineering, and clinical partnerships to advance regenerative medicine.